REBECCA FOWLKES: Open Payments
NPI 1427290071 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$89 in 2 payments from 2 companies in 2025. Trend: 2023 $217 · 2024 $120 · 2025 $89
Food & beverage: $89
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
Products named: Auvelity, CAPLYTA.
Industry payments across CA — which companies pay providers there.
